Genetic alterations in gallbladder carcinoma

被引:36
作者
Kuroki, T [1 ]
Tajima, Y [1 ]
Matsuo, K [1 ]
Kanematsu, T [1 ]
机构
[1] Nagasaki Univ, Grad Sch Biomed Sci, Dept Transplantat & Digest Surg, Nagasaki 8528501, Japan
关键词
loss of heterozygosity; gallbladder carcinoma; tumor suppressor gene;
D O I
10.1007/s00595-004-2906-2
中图分类号
R61 [外科手术学];
学科分类号
摘要
Gallbladder carcinoma is an aggressive cancer associated with a poor prognosis. Unfortunately, the precise molecular mechanisms of development and progression of this highly malignant tumor remain unknown. It is still unclear whether loss of heterozygosity (LOH) plays a significant role in gallbladder carcinogenesis, but recent studies have found a high incidence of LOH at several chromosomes in gallbladder carcinoma. In particular, LOH on chromosomes 1p, 3p, 5p, 8p, 9p, 9q, 13q, 16q, and 17p has been highlighted and LOH on 3p, 9p, 13q, 16q, and 17p has been detected in preneoplastic lesions and in the early phase of gallbladder carcinoma during multistep carcinogenesis. The proto-oncogene, K-ras, is the best known genetic alteration in several human neoplasms, including gallbladder carcinoma. The accumulation of these genetic changes leads to a disruption in cell-cycle regulation and also continuous cell proliferation. We present an overview of K-ras alteration and LOH at several chromosome loci in gallbladder carcinoma. Further studies of the molecular mechanism in gallbladder carcinoma and the delineation of the genetic influence involved should promote our understanding of gallbladder carcinogenesis.
引用
收藏
页码:101 / 105
页数:5
相关论文
共 48 条
[1]   K-ras gene mutation in gall bladder carcinomas and dysplasia [J].
Ajiki, T ;
Fujimori, T ;
Onoyama, H ;
Yamamoto, M ;
Kitazawa, S ;
Maeda, S ;
Saitoh, Y .
GUT, 1996, 38 (03) :426-429
[2]  
ALDAZ CM, 1995, CANCER RES, V55, P3976
[3]  
Bando K, 2000, GENE CHROMOSOME CANC, V28, P38, DOI 10.1002/(SICI)1098-2264(200005)28:1<38::AID-GCC5>3.0.CO
[4]  
2-A
[5]  
Bednarek AK, 2000, CANCER RES, V60, P2140
[6]   DIFFUSE LARGE-CELL LYMPHOMAS EXHIBIT FREQUENT DELETIONS IN 9P21-22 AND 9Q31-34 REGIONS [J].
CHAGANTI, SR ;
GAIDANO, G ;
LOUIE, DC ;
DALLAFAVERA, R ;
CHAGANTI, RSK .
GENES CHROMOSOMES & CANCER, 1995, 12 (01) :32-36
[7]  
Chang HJ, 1999, MODERN PATHOL, V12, P763
[8]   Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3 [J].
Dammann, R ;
Li, C ;
Yoon, JH ;
Chin, PL ;
Bates, S ;
Pfeifer, GP .
NATURE GENETICS, 2000, 25 (03) :315-319
[9]  
Donohue JH, 1998, CANCER, V83, P2618, DOI 10.1002/(SICI)1097-0142(19981215)83:12<2618::AID-CNCR29>3.0.CO
[10]  
2-H